4 Firms Guide GSK's $2B Bellus Cough Drug Co. Takeover
Pharmaceuticals giant GSK PLC, the former GlaxoSmithKline, said on Tuesday that it has agreed to buy Canadian respiratory treatment company Bellus Health Inc. in an all-cash deal valued at $2 billion....To view the full article, register now.
Already a subscriber? Click here to view full article